Conclusion Edaravone is safe and effective in the treatment of brain damage secondary to hypertension intracerebral hemorrhage.
结论依达拉奉对高血压脑出血继发性脑损伤的治疗是安全有效的。
Compared with initial intracerebral hemorrhage, the patients with recurrent intracerebral hemorrhage almost have hypertension, the long course and bad prognosis.
与首次患者相比再发性脑出血多有高血压病，病程较长且预后不良。
Compared with initial intracerebral hemorrhage, the patients with recurrent intracerebral hemorrhage almost have hypertension, the long course and bad prognosis.
与首次患者相比再发性脑出血多有高血压病，病程较长且预后不良。
应用推荐